2-oxindole has been researched along with Intraocular Pressure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Beznos, OV; Chesnokova, NB; Efremov, AM; Eremeev, RO; Lozinskaya, NA; Milaeva, ER; Shevtsova, EF | 1 |
| Beznos, OV; Chesnokova, NB; Lozinskaya, NA; Volkova, MS; Zaryanova, EV; Zefirov, NS | 1 |
| Beznos, OV; Chesnokova, NB; Grigoryev, AV; Lozinskaya, NA; Volkova, MS; Zaryanova, EV; Zefirov, NA | 1 |
3 other study(ies) available for 2-oxindole and Intraocular Pressure
| Article | Year |
|---|---|
Microwave-Assisted Synthesis of 3-Hydroxy-2-oxindoles and Pilot Evaluation of Their Antiglaucomic Activity.
Topics: Animals; Intraocular Pressure; Microwaves; Neurodegenerative Diseases; Oxindoles; Pilot Projects; Rabbits | 2023 |
Oxindole-based intraocular pressure reducing agents.
Topics: Crystallography, X-Ray; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Indoles; Intraocular Pressure; Ligands; Models, Molecular; Molecular Structure; Oxindoles; Quinone Reductases; Structure-Activity Relationship; Time Factors | 2017 |
[Novel agonists of melatonin receptors as promising hypotensive and neuroprotective agents for therapy of glaucoma].
Topics: Animals; Antioxidants; Drug Design; Gene Expression; Glaucoma; Indoles; Intraocular Pressure; Ligands; Male; Melatonin; Neuroprotective Agents; Ocular Hypertension; Oxidation-Reduction; Oxindoles; Prospective Studies; Protein Binding; Rabbits; Receptors, Melatonin; Structure-Activity Relationship | 2017 |